Cargando…
Evaluating the Antiparasitic Activity of Novel BPZ Derivatives Against Toxoplasma gondii
Prevalence studies revealed that one-third of the human population is chronically infected with Toxoplasma gondii. Presently, such infections are without medical treatment that effectively eradicates the parasite once it is in its latent form. Moreover, the therapeutics used to treat acute infection...
Autores principales: | Hatton, Olivia, Stitzlein, Lea, Dudley, Richard W., Charvat, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466062/ https://www.ncbi.nlm.nih.gov/pubmed/32751616 http://dx.doi.org/10.3390/microorganisms8081159 |
Ejemplares similares
-
Exploring the Antiparasitic Activity of Tris-1,3,4-Thiadiazoles against Toxoplasma gondii-Infected Mice
por: Almutairi, Tahani M., et al.
Publicado: (2022) -
Synthesis, characterization, and antiparasitic effects of zinc oxide nanoparticles-eugenol nanosuspension against Toxoplasma gondii infection
por: Cheraghipour, Kourosh, et al.
Publicado: (2023) -
Identification of Fis1 Interactors in Toxoplasma gondii Reveals a Novel Protein Required for Peripheral Distribution of the Mitochondrion
por: Jacobs, Kylie, et al.
Publicado: (2020) -
Toxoplasma gondii in the Food Supply
por: Hussain, Malik A., et al.
Publicado: (2017) -
Oxidative stress generated during monensin treatment contributes to altered Toxoplasma gondii mitochondrial function
por: Charvat, Robert A., et al.
Publicado: (2016)